FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

598711000001103: Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16566901000001117 Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16567001000001118 Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has active ingredient Ranitidine false Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Is a Zaedoc true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) 60 tablet 4 x 15 tablets Is pack of False Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) 60 tablet 4 x 15 tablets Has AMP True Zaedoc 150 tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start